The focus should be on the main pillars of Growth, as the company announced on Wednesday in Kenilworth at the same time, with the figures for the quarter. The business with women's health, as well as the with copycat drugs belongs. The reorganization is expected to be completed by the end of the first half of the year 2021. Merck & co. will benefit more from the growth in cancer medicine, vaccines and animal health. Merck & co. 80,60 sq EUR +1,60 (+2,03%) Tradegate

• 1 day
• 6 months

To the price data in The fourth quarter for the group, meanwhile, more or less as analysts expected. Sales rose from October and December by eight percent to 11.9 billion dollars (10,77 billion euros). Thus, the company was, however, minimal of expectations. The to To sales, purchases, conversion costs and other special items, adjusted earnings per share was slightly above what is expected analysts and increased by 12 percent to 1.16 dollars.

Merck bolt-on targets to the top - the increase in turnover in view

The group had lowered its targets in the past year, upwards several times. At the end of the Merck & Co sets throughout the year, 46.8 billion dollars and was therefore at the upper end of the guidance range of 46.5 and 47 billion dollars. The good business with the cancer drug Keytruda were awarded to the pharmaceutical giant in the course of the year boost. The adjusted earnings per share reached in 2019 5,19 dollars.

In the current fiscal year, Merck&Co wants to increase its sales further. The target value is located between the 48.8 and 50.3 billion dollars. The earnings per share should reach 5,62 up to 5,77 Dollar. Price manipulating Central banks in the gold? Expert explains what is behind the rumor FOCUS Online Gold-expert Thorsten Polleit: the price Manipulating banks of the gold? Expert explains what is behind the rumor "In Frankfurt, he buys Coca": Christoph Daum of Fans in the ICE FOCUS Online/Wochit mocked Loud singing in the train: "In Frankfurt, he buys Coca": Christoph Daum of Fans in the ICE

ham/dpa mocked-AFX Date Of Update: 05 February 2020, 15:00